IL13 and Alzheimer disease: In addition, the administration of LTE effectively inhibits the elevation of serum total IgE levels and pro-inflammatory cytokine production in AD experimental models; these effects may be attributable to the inhibition of JAK-STAT signaling mediated by decreased IL-13 levels.